A randomized controlled multicentre clinical trial of levofloxacin sequential therapy compared with combination therapy with cefuroxime and azithromycin in patients with community-acquired pneumonia
Abstract
Objective To evaluate the clinical consequences and cost-effectiveness of levofloxacin sequential therapy(intravenous infusion followed by oral administration) in patients with community-acquired pneumonia.Methods Combination therapy with cefuroxime and azithromycin was used as control regimen.A randomized controlled multicentre clinical trial was conducted to evaluate the efficacy,safety and cost-effectiveness of levofloxacin in patients with community-acquired pneumonia.Results Of the total 378 cases with community-acquired pneumonia,190 were treated with sequential levofloxacin,188 were treated with cefuroxime plus azithromycin.In the levofloxacin treatment group,the cure and efficacy rate were 67.37% and 96.84% respectively.The bacterial eradication rate was 96.77%.The incidence of adverse drug reaction was 10.53%.In cefuroxime and azithromycin combination group,the cure and efficacy rate were 64.36% and 96.28% respectively.The bacterial eradication rate was 96.67%.The incidence of adverse drug reaction was 7.98%.There was no significant difference between the two groups in terms of these parameters.The mean duration of treatment,days of hospital stay,and cost of hospitalization did not show significant difference between the two groups.However,levofloxacin sequential therapy(cost of 32.01) was more cost-effective than cefuroxime plus azithromycin(cost of 38.51).The difference was statistically significant.Conclusions Levofloxacin sequential therapy is efficacious,safe…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.